Short answer
Immunovant, Inc. (IMVT) filed an 8-K current report with the SEC on May 20, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal fourth-quarter and fiscal-year results covered period ended March 31, 2026.
Immunovant, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal fourth-quarter and fiscal-year results covered period ended March 31, 2026
- Press release issued May 20, 2026 and furnished as Exhibit 99.1
- Investors should review Exhibit 99.1 for financial results and management commentary
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Immunovant, Inc. 8-K filings
Get the next IMVT 8-K as it lands
Follow IMVT for push alerts, or ask the research agent what this filing means.